| Literature DB >> 30781874 |
Marcelina Mazur1, Witold Gładkowski2, Aleksandra Pawlak3, Bożena Obmińska-Mrukowicz4, Gabriela Maciejewska5, Czesław Wawrzeńczyk6.
Abstract
Searching for the new anticancer compounds we prepared three new β-cyclocitral-derived hydroxyl-γ-lactones by microbial hydroxylation of tetramethyl-substituted bicyclic γ-lactone. The substrate was transformed by the enzymatic system of filamentous fungi. Three out of fifteen strains were selected as effective biocatalysts (Fusarium culmorum AM10, Armillaria mellea AM296, Trametes versicolor AM536). The hydroxylation processes were not only regioselective but also stereoselective. The hydroxylation products of each secondary carbon atom in the cyclohexane ring were obtained by the application of the selected fungal strains. The Fusarium culmorum AM10 introduced the hydroxy function at C-3 and C-4, Armillaria mellea AM296 incorporated the hydroxy function at C-3 and C-5 and Trametes versicolor AM536 transformed the substrate to the mixture of C-3, C-4 and C-5 hydroxylactones. The hydroxylactones obtained were enantiomericaly enriched (ee values in the range 17⁻99%). The in vitro antiproliferative activities of the functionalization products were also evaluated. Regardless of the hydroxy substituent location all tested lactones exhibited similar, significant activity towards selected cancer cell lines (IC50 in the range 22.8⁻33.9 µg/mL).Entities:
Keywords: Armillaria mellea; Fusarium culmorum; Trametes versicolor; antiproliferative activity; asymmetric hydroxylation
Mesh:
Substances:
Year: 2019 PMID: 30781874 PMCID: PMC6412764 DOI: 10.3390/molecules24040666
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
The composition (in % according to GC) of the products’ mixtures of screening biotransformations of lactone 1.
| Strain | Time of Incubation (days) | Lactone 1 | Biotransformation Products | ||
|---|---|---|---|---|---|
| 2 | 3 | 4 | |||
| 2 | 35 | 28 | 37 | - | |
| 4 | 19 | 32 | 49 | - | |
| 7 | 7 | 41 | 52 | - | |
| 10 | 1 | 45 | 53 | - | |
| 12 | 0 | 46 | 53 | - | |
| 2 | 41 | 53 | - | 6 | |
| 4 | 13 | 70 | - | 17 | |
| 7 | 0 | 75 | - | 25 | |
| 2 | 55 | 31 | 3 | 11 | |
| 4 | 20 | 59 | 6 | 15 | |
| 7 | 9 | 68 | 6 | 17 | |
| 10 | 3 | 71 | 7 | 19 | |
| 12 | 2 | 71 | 8 | 19 | |
| 14 | 2 | 72 | 8 | 18 | |
Scheme 1Biohydroxylation of lactone 1. The structures present relative stereochemistry.
Figure 1Determination of the hydroxyl function location using relevant H-C correlations from the HMBC spectra.
Scheme 2Biotransformation of lactone 1 in A. mellea AM296 culture. The structures present relative stereochemistry.
Scheme 3Products mixtures obtained in T. versicolor AM536 culture. The structures present relative stereochemistry.
The antiproliferative activity of hydroxylactones 2, 3, 4 and control – Etoposide against the selected cancer cell lines expressed as IC50.
| Cell Line | Compound (IC50 µg/mL) | |||
|---|---|---|---|---|
| 2 | 3 | 4 | Etoposide | |
| CLB 70 | 33.21 ± 2.14 a1 | 32.43 ± 1.72 a | 33.97 ± 3.66 a | 14.31 ± 2.83 |
| GL-1 | 28.67 ± 1.91 a | 26.76 ± 5.65 a | 22.75 ± 1.27 a | 4.4 ± 1.14 |
a 1The values in the same row, followed by the same letter, are not statistically different (p < 0.05).